Credit Suisse’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-501
| Closed | -$172K | – | 3611 |
|
|
2019
Q3 | $172K | Sell |
501
-7
| -1% | -$2.4K | ﹤0.01% | 3225 |
|
|
2019
Q2 | $467K | Buy |
508
+23
| +5% | +$21.1K | ﹤0.01% | 2828 |
|
|
2019
Q1 | $774K | Sell |
485
-174
| -26% | -$278K | ﹤0.01% | 2538 |
|
|
2018
Q4 | $1.23M | Buy |
659
+12
| +2% | +$22.4K | ﹤0.01% | 2147 |
|
|
2018
Q3 | $1.53M | Buy |
647
+32
| +5% | +$75.4K | ﹤0.01% | 2136 |
|
|
2018
Q2 | $2.12M | Sell |
615
-72
| -10% | -$248K | ﹤0.01% | 2022 |
|
|
2018
Q1 | $1.95M | Sell |
687
-60
| -8% | -$170K | ﹤0.01% | 2081 |
|
|
2017
Q4 | $1.92M | Sell |
747
-108
| -13% | -$278K | ﹤0.01% | 2042 |
|
|
2017
Q3 | $2.43M | Sell |
855
-121
| -12% | -$344K | ﹤0.01% | 1985 |
|
|
2017
Q2 | $2.31M | Sell |
976
-343
| -26% | -$811K | ﹤0.01% | 1819 |
|
|
2017
Q1 | $3.32M | Buy |
1,319
+154
| +13% | +$388K | ﹤0.01% | 1672 |
|
|
2016
Q4 | $2.63M | Buy |
1,165
+346
| +42% | +$781K | ﹤0.01% | 1926 |
|
|
2016
Q3 | $2.05M | Sell |
819
-280
| -25% | -$702K | ﹤0.01% | 2080 |
|
|
2016
Q2 | $3.36M | Buy |
1,099
+363
| +49% | +$1.11M | ﹤0.01% | 1712 |
|
|
2016
Q1 | $2.34M | Buy |
736
+231
| +46% | +$733K | ﹤0.01% | 1859 |
|
|
2015
Q4 | $2.59M | Sell |
505
-187
| -27% | -$960K | ﹤0.01% | 1934 |
|
|
2015
Q3 | $2.2M | Sell |
692
-231
| -25% | -$735K | ﹤0.01% | 2034 |
|
|
2015
Q2 | $3.69M | Buy |
923
+375
| +68% | +$1.5M | ﹤0.01% | 1823 |
|
|
2015
Q1 | $2.19M | Sell |
548
-88
| -14% | -$352K | ﹤0.01% | 2086 |
|
|
2014
Q4 | $3.12M | Sell |
636
-240
| -27% | -$1.18M | ﹤0.01% | 1872 |
|
|
2014
Q3 | $3.56M | Buy |
876
+228
| +35% | +$927K | ﹤0.01% | 1739 |
|
|
2014
Q2 | $2.62M | Buy |
648
+307
| +90% | +$1.24M | ﹤0.01% | 2145 |
|
|
2014
Q1 | $1.55M | Sell |
341
-1,230
| -78% | -$5.6M | ﹤0.01% | 2414 |
|
|
2013
Q4 | $5.51M | Buy |
1,571
+1,123
| +251% | +$3.94M | 0.01% | 1497 |
|
|
2013
Q3 | $1.84M | Buy |
448
+190
| +74% | +$780K | ﹤0.01% | 2109 |
|
|
2013
Q2 | $1.02M | Buy |
+258
| New | +$1.02M | ﹤0.01% | 2427 |
|